FAST AND CALIBRATION FREE DETERMINATION OF FIRST ORDER REACTION
KINETICS IN API-SYNTHESIS USING IN-SITU ATR-FTIR
1
,3
1
2
2,3
1,3*
Moritz C. Rehbein , Sascha Husmann , Christian Lechner , Conrad Kunick , Stephan Scholl
1
2
TU Braunschweig, Institute for Medicinal and Pharmaceutical Chemistry, Beethovenstraße 55, 38106
Braunschweig
3
TU Braunschweig, Center for Pharmaceutical Engineering, Franz-Liszt-Straße 35a, 38106 Braunschweig
ABSTRACT: In early stages of drug development only sparse amounts of the key substances are available,
which is problematic for the determination of important process data like reaction kinetics. Therefore, it is
important to perform experiments as economically as possible, especially in regards to limiting compounds. Here
we demonstrate the use of a temperature step experiment enabling the determination of complete reaction
kinetics in a single non-isothermal experiment. In contrast to the traditionally used HPLC, the method takes
advantage of the high measuring rate and the low amount of labor involved in using in-situ ATR-FTIR to
determine time-dependent concentration-equivalent data.
Keywords: API; synthesis; in-situ FTIR; reaction kinetics
1
. INTRODUCTION
During the process development for new API (active pharmaceutical ingredients), different properties of the
substances and processes involved have to be determined. These are for example solubility (solvent selection),
reaction kinetics (reaction characterization and optimization) and caloric data. Especially in the early stages of
drug substance development, only sparse amounts of the required substances are available to perform the above
tasks, hindering rapid process development [1].
For the determination of reaction kinetics, usually sampling and subsequent HPLC analysis is used to derive
time-dependent concentration profiles of the reactant with good accuracy. However, this method has some
limitations due to slow and manual sampling and the time- and labor-demand for sample preparation. These
disadvantages can be overcome by in-situ ATR-FTIR. The low amount of labor involved and the high sampling
rates possible with this technique can enable information rich and material saving experiments.
Kinetic analysis of chemical reactions has been under investigation for many years now. For first order reactions
the standard procedure is to plot the logarithm of the reactant concentration or concentration-equivalent physical
property over time and determine the reaction rate constant as the slope of the resulting straight line [2,3].
Various researchers have extended this principle approach by the development of specialized and more accurate
methods, applicable for example, when the initial reactant concentration cannot be determined [2,4]. For more
complex reactions, Mauser proposed a method to determine kinetics from spectroscopic data [5,6]. However, the
straightforward linearized plotting and determination of the slope is the standard procedure [3] and might still be
practical for first order reactions in most cases.
The determination of first order reaction kinetics directly from FTIR-signals using the standard plotting method
has also been demonstrated before. Krappitz et al. [7] and Xiao et al. [8] calculate reaction rate constants directly
from absorbance signals. In this contribution, a similar method for the determination of first order reaction
kinetics utilizing in-situ ATR-FTIR is demonstrated. However, compared to the isothermal approaches described
by Krappitz and Xiao, our method enables the computation of Arrhenius parameters (E
carefully designed, non-isothermal experiment.
A 0
, k ) from just one
As a model reaction (Figure 1, (iii)), a dealkoxycarbonylation [9–11] was used to synthesize the
pharmaceutically relevant scaffold 3,4-dihydro-1H-1-benzazepine-2,5-dione (3) from the enolized 3-
oxocarboxylic ester 2 as starting material. The procedure is carried out under neutral conditions in wet DMSO at
elevated temperatures [12]. 3,4-Dihydro-1H-1-benzazepine-2,5-dione (3) and its derivatives are used as platform
molecules for the synthesis of various protein kinase inhibitors and anticancer agents [13–18].
In the following, the development of the method as well as its application on the model system and a validation
with data derived from conventional HPLC measurements is presented.
1